Eli Lilly and Company (LLY)

NYSE · Healthcare · Drug Manufacturers - General
$1,347.11-0.30%As of 2026-11-22 · USD
Last session low $1,341.77Last session high $1,372.05
52-week low $850.5152-week high $1,475.25
Market cap
$1.20T
Sector
Healthcare
P/E (TTM)
43.7x
Dividend yield
0.51%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)50.2In the neutral range (30 to 70)
MACD (12, 26, 9)33.57Below its signal line (46.71); histogram -13.14
Bollinger %B (20, 2)32%Inside the bands (1,281.76 to 1,486.48)
SMA 201,384.12Price is 2.7% below
SMA 501,267.00Price is 6.3% above
SMA 2001,117.32Price is 20.6% above
ATR (20)3.08% of priceAverage true range per day
52-week position79%In the upper part of the 850.51 to 1,475.25 range

About Eli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Insider filings, 90 daysNo purchases and 1 sale (about $7.0M).
Latest fiscal yearEnded 2025-12-31: revenue of $65.18B and an operating margin of 45.6%.

More in Drug Manufacturers - General